摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[3-(2R,3R)-4R]-3-(3-hydroxy-2,4-dimethyl-1-oxopent-4-enyl)-4-(phenylmethyl)]-2-oxazolidinone | 186885-60-9

中文名称
——
中文别名
——
英文名称
[[3-(2R,3R)-4R]-3-(3-hydroxy-2,4-dimethyl-1-oxopent-4-enyl)-4-(phenylmethyl)]-2-oxazolidinone
英文别名
(4R)-4-benzyl-3-[(2R,3R)-3-hydroxy-2,4-dimethylpent-4-enoyl]-1,3-oxazolidin-2-one
[[3-(2R,3R)-4R]-3-(3-hydroxy-2,4-dimethyl-1-oxopent-4-enyl)-4-(phenylmethyl)]-2-oxazolidinone化学式
CAS
186885-60-9
化学式
C17H21NO4
mdl
——
分子量
303.358
InChiKey
NZNQVFXLNMUYFI-YUELXQCFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    485.7±38.0 °C(Predicted)
  • 密度:
    1.201±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    66.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Stereoselectivity of model C22–23 aldol coupling for spirangiens A & B
    作者:Claire Gregg、Michael V. Perkins
    DOI:10.1016/j.tet.2012.10.008
    日期:2013.1
    the key C22–23 aldol coupling for the synthesis of spirangiens A & B. The lithium enolate of model ketone 3 was coupled with the differently protected aldehydes 4 (acetonide) and 5 (silyl) giving 3:1 and 3.5:1 dr, respectively, in favour of the unnatural (S) isomer in both cases. The lack of any significant effect on the aldol stereoselectivity induced by the aldehyde protecting groups contrasts with
    制备了一个模型系统,以研究关键的C22-23醛醇偶合体对合成螺旋藻A和B的非对映选择性。模型3的烯醇锂与不同保护的醛4(丙酮化物)和5(甲硅烷基)结合,在两种情况下,分别使用3:1和3.5:1 dr都支持非天然(S)异构体。由醛保护基诱导的对醛醇的立体选择性没有任何显着影响,这与以前的文献报道形成了对比。
  • A synthetic approach to the phorboxazoles – Synthesis of the C20–C32 central core
    作者:James W. Leahy、Stephen J. Boyer
    DOI:10.1016/j.tetlet.2017.07.009
    日期:2017.8
    An enantiospecific synthesis of the C20–C32 central core of the phorboxazole scaffold, including the non-macrocyclic oxazole is detailed in 17 steps (longest linear sequence) from methacrolein in 7.8% overall yield. All of the stereocenters are communicated from a single Evans aldol reaction, and the final compound is suitably functionalized for further elaboration to the natural products.
    从甲基丙烯醛以17个步骤(最长的线性序列)详细描述了佛波唑支架(包括非大环恶唑)的C20–C32中央核的对映体特异性合成,总产率为7.8%。所有的立构中心都是通过一个单一的Evans醛醇缩合反应进行的,最终化合物经过适当官能化处理,可以进一步精制天然产物。
  • [EN] ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF<br/>[FR] ANALOGUES DE DISCODERMOLIDE ET DE DICTYOSTATINE-1, INTERMEDIAIRES CORRESPONDANTS, ET PROCEDES DE SYNTHESE CORRESPONDANTS
    申请人:UNIV PITTSBURGH
    公开号:WO2004022552A1
    公开(公告)日:2004-03-18
    A compound of the following structure: wherein R1 is H, an alkyl group, an aryl group, an alkenyl group, an alkynyl group, or a halogen atom; R2 is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; Ra, Rb and Rc are independently an alkyl group or an aryl group; Rd is an alkyl group, an aryl group, an alkoxylalkyl group, -RiSiRaRbRc or a benzyl group, wherein Ri is an alkylene group; Re is an alkyl group, an allyl group, a benzyl group, an aryl group, an alkoxy group, or -NRgRh, wherein Rg and Rh are independently H, an alkyl group or an aryl group; R3 is (CH2)n where n is and integer in the range of 0 to 5, -CH2CH(CH3)-, -CH=CH-, -CH=C(CH3)-, or -C=-C-; R4 is (CH2)p where p is an integer in the range of 4 to 12, -(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-, -(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-, wherein y1 and y2 are 1 and y3, y4 and y5 are independently 0 or 1, Rk1, Rk2, Rk3, Rk4 and Rk5 are independently H, CH3, or OR2a, and Rs1, Rs2, Rs3, and Rs4 are independently H or CH3, wherein R2a is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; and R5 is H or OR2b, wherein R2b is H, an alkyl group, an aryl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; provided that the compound is not dictyostatin 1.
    以下是该结构的化合物:其中R1为H、烷基基团、芳基、烯基基团、炔基基团或卤素原子;R2为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;Ra、Rb和Rc独立地为烷基基团或芳基;Rd为烷基基团、芳基、烷氧基烷基团、-RiSiRaRbRc或苄基,其中Ri为烷基烷基团;Re为烷基基团、烯丙基基团、苄基、芳基、烷氧基或-NRgRh,其中Rg和Rh独立地为H、烷基基团或芳基;R3为(CH2)n,其中n为0到5范围内的整数,-CH2CH(CH3)-、-CH=CH-、-CH=C(CH3)-或-C=-C-;R4为(CH2)p,其中p为4到12范围内的整数,-(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rs I)CH(Rs2)C(Rs3)=C(Rs4)-、-(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-、-(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-,其中y1和y2为1,y3、y4和y5独立地为0或1,Rk1、Rk2、Rk3、Rk4和Rk5独立地为H、CH3或OR2a,Rs1、Rs2、Rs3和Rs4独立地为H或CH3,其中R2a为H、烷基基团、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;R5为H或OR2b,其中R2b为H、烷基基团、芳基、芳基、苄基、三苄基、-SiRaRbRc、CH2ORd或CORe;前提是该化合物不是dictyostatin 1。
  • Effect of Substituents on the Ring-Closing Metathesis Reaction in the Synthesis of Functionalized Nonanolactones
    作者:Rosario Hernández-Galán、Jacinto Ramírez-Fernández、Isidro Collado
    DOI:10.1055/s-2008-1032072
    日期:2008.2
    The synthesis of functionalized nine-membered ring lactones based on sequential esterification and ring-closing metathesis (RCM) reactions is reported. The effects of olefin substitution and allylic and homoallylic oxygenated substituents on the RCM reaction is analyzed. An unusual cyclization stereochemistry has been observed, leading to a stereoselective olefin formation in the synthesis of nonanolactones
    报道了基于顺序酯化和闭环复分解 (RCM) 反应的功能化九元环内酯的合成。分析了烯烃取代和烯丙基和高烯丙基氧化取代基对RCM反应的影响。观察到一种不寻常的环化立体化学,导致在壬内酯合成中形成立体选择性烯烃。高选择性可以通过均烯丙基或烯丙基羟基与钌金属中心在钌环丁烷中间体中的相互作用/配位来合理化。
  • Studies on the total synthesis of sanglifehrin A: stereoselective synthesis of the C(29)–C(39) fragment
    作者:Luiz C. Dias、Airton G. Salles
    DOI:10.1016/j.tetlet.2006.01.105
    日期:2006.3
    A highly stereoselective synthesis of the C(29)–C(39) fragment of the potent immunosuppressant sanglifehrin A has been accomplished by a sequence involving 16 steps (18% overall yield) from N-propionyloxazolidinone 9. Key steps are a diastereoselective hydroboration, and a diastereoselective epoxidation of an allylic alcohol followed by a 1,5-anti boron-mediated aldol reaction of methyl ketone 4 with
    在C(29)-C(39)的有效的免疫抑制剂萨菲菌素A的片段的高度立体选择性合成已经由从包括16步(18%总收率)的序列来完成Ñ -propionyloxazolidinone 9。关键步骤是非对映选择性的硼氢化反应,以及烯丙醇的非对映选择性环氧化,然后是甲基酮4与手性醛5的1,5-抗硼介导的羟醛缩合反应。
查看更多

同类化合物

(R)-4-异丙基-2-恶唑烷硫酮 麻黄恶碱 顺-八氢-2H-苯并咪唑-2-酮 顺-1-(4-氟苯基)-4-[1-(4-氟苯基)-4-羰基-1,3,8-三氮杂螺[4.5]癸-8-基]环己甲腈 非达司他 降冰片烯缩醛3-((1S,2S,4S)-双环[2.2.1]庚-5-烯-2-羰基)恶唑烷-2-酮 阿齐利特 阿那昔酮 阿洛双酮 阿帕鲁胺 阿帕他胺杂质2 铟烷-2-YL-甲基胺盐酸 钠2-{[4,5-二羟基-3-(羟基甲基)-2-氧代-1-咪唑烷基]甲氧基}乙烷磺酸酯 重氮烷基脲 詹氏催化剂 解草恶唑 解草噁唑 表告依春 螺莫司汀 螺立林 螺海因氮丙啶 螺[1-氮杂双环[2.2.2]辛烷-8,5'-咪唑烷]-2',4'-二酮 苯甲酸,4-氟-,2-[5,7-二(三氟甲基)-1,8-二氮杂萘-2-基]-2-甲基酰肼 苯氰二硫酸,1-氰基-1-甲基-4-氧代-4-(2-硫代-3-噻唑烷基)丁酯 苯妥英钠杂质8 苯妥英-D10 苯妥英 苯基硫代海因半胱氨酸钠盐 苯基硫代乙内酰脲-谷氨酸 苯基硫代乙内酰脲-蛋氨酸 苯基硫代乙内酰脲-苯丙氨酸 苯基硫代乙内酰脲-色氨酸 苯基硫代乙内酰脲-脯氨酸 苯基硫代乙内酰脲-缬氨酸 苯基硫代乙内酰脲-异亮氨酸 苯基硫代乙内酰脲-天冬氨酸 苯基硫代乙内酰脲-亮氨酸 苯基硫代乙内酰脲-丙氨酸 苯基硫代乙内酰脲-D-苏氨酸 苯基硫代乙内酰脲-(NΕ-苯基硫代氨基甲酰)-赖氨酸 苯基乙内酰脲-甘氨酸 苏氨酸-1-(苯基硫基)-2,4-咪唑烷二酮(1:1) 色氨酸标准品002 膦酸,(2-羰基-1-咪唑烷基)-,二(1-甲基乙基)酯 脱氢-1,3-二甲基尿囊素 聚(d(A-T)铯) 羟甲基-5,5-二甲基咪唑烷-2,4-二酮 羟基香豆素 美芬妥英 美芬妥英